A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 10,721 shares of MRNA stock, worth $422,300. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,721
Previous 10,611 1.04%
Holding current value
$422,300
Previous $1.26 Million 43.17%
% of portfolio
0.02%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $7,000 - $13,765
110 Added 1.04%
10,721 $716,000
Q2 2024

Aug 15, 2024

BUY
$101.21 - $166.61 $8,602 - $14,161
85 Added 0.81%
10,611 $1.26 Million
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $2,219 - $3,001
26 Added 0.25%
10,526 $1.12 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $3,405 - $5,117
49 Added 0.47%
10,500 $1.04 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $10,605 - $13,927
110 Added 1.06%
10,451 $1.08 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $5,214 - $7,063
-44 Reduced 0.42%
10,341 $1.26 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $4,069 - $5,910
30 Added 0.29%
10,385 $1.59 Million
Q4 2022

Feb 21, 2023

SELL
$118.38 - $210.04 $253,451 - $449,695
-2,141 Reduced 17.13%
10,355 $1.86 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $157,623 - $259,230
-1,335 Reduced 9.65%
12,496 $1.48 Million
Q2 2022

Aug 04, 2022

SELL
$117.13 - $176.59 $23,543 - $35,494
-201 Reduced 1.43%
13,831 $1.98 Million
Q1 2022

May 09, 2022

SELL
$126.46 - $235.05 $232,307 - $431,786
-1,837 Reduced 11.58%
14,032 $2.42 Million
Q4 2021

Feb 03, 2022

SELL
$225.82 - $368.51 $18,291 - $29,849
-81 Reduced 0.51%
15,869 $4.03 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $3.54 Million - $7.73 Million
15,950 New
15,950 $6.14 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.